- Type / Class
- Equity / Common Stock
- Shares outstanding
- 123,850,680
- Total 13F shares
- 92,085,897
- Share change
- -1,972,098
- Total reported value
- $9,209,883,362
- Put/Call ratio
- 55%
- Price per share
- $100.02
- Number of holders
- 379
- Value change
- -$251,467,115
- Number of buys
- 173
- Number of sells
- 182
Quarterly Holders Quick Answers
What is CUSIP 40131M109?
CUSIP 40131M109 identifies GH - Guardant Health, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 40131M109:
Top shareholders of GH - Guardant Health, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
7%
|
8,704,930
|
$1,088,203,000 | — | 30 Sep 2021 | |
| FMR LLC |
13F
|
Company |
5.2%
|
6,414,310
|
$801,853,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
4.5%
|
5,560,641
|
$695,134,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.5%
|
5,555,998
|
$694,554,000 | — | 30 Sep 2021 | |
| Capital Research Global Investors |
13F
|
Company |
4.3%
|
5,286,792
|
$660,902,000 | — | 30 Sep 2021 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
4%
|
4,894,936
|
$611,916,000 | — | 30 Sep 2021 | |
| Clearbridge Investments, LLC |
13F
|
Company |
2.9%
|
3,602,966
|
$450,407,000 | — | 30 Sep 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.5%
|
3,156,923
|
$394,647,000 | — | 30 Sep 2021 | |
| COATUE MANAGEMENT LLC |
13F
|
Company |
2.3%
|
2,805,273
|
$350,687,000 | — | 30 Sep 2021 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
2,663,622
|
$332,979,000 | — | 30 Sep 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.8%
|
2,271,403
|
$283,948,000 | — | 30 Sep 2021 | |
| Capital International Investors |
13F
|
Company |
1.7%
|
2,153,075
|
$269,156,000 | — | 30 Sep 2021 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
1.4%
|
1,790,075
|
$223,777,000 | — | 30 Sep 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.4%
|
1,751,944
|
$219,010,000 | — | 30 Sep 2021 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
1.3%
|
1,613,007
|
$201,642,000 | — | 30 Sep 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.3%
|
1,607,527
|
$200,957,000 | — | 30 Sep 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
1.1%
|
1,328,441
|
$166,068,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
1,311,886
|
$163,999,000 | — | 30 Sep 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.99%
|
1,227,400
|
$153,437,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.99%
|
1,222,173
|
$152,783,000 | — | 30 Sep 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.98%
|
1,214,949
|
$151,881,000 | — | 30 Sep 2021 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.91%
|
1,131,097
|
$141,399,000 | — | 30 Sep 2021 | |
| BAMCO INC /NY/ |
13F
|
Company |
0.91%
|
1,130,049
|
$141,267,000 | — | 30 Sep 2021 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.84%
|
1,042,729
|
$130,352,000 | — | 30 Sep 2021 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.84%
|
1,034,912
|
$129,374,000 | — | 30 Sep 2021 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.75%
|
925,342
|
$115,677,000 | — | 30 Sep 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.74%
|
917,075
|
$114,642,000 | — | 30 Sep 2021 | |
| NORGES BANK |
13F
|
Company |
0.63%
|
784,320
|
$98,048,000 | — | 30 Sep 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.62%
|
770,212
|
$96,284,000 | — | 30 Sep 2021 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.55%
|
676,944
|
$84,625,000 | — | 30 Sep 2021 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.52%
|
643,600
|
$80,457,000 | — | 30 Sep 2021 | |
| SB INVESTMENT ADVISERS (UK) LTD |
13F
|
Company |
0.49%
|
603,943
|
$75,499,000 | — | 30 Sep 2021 | |
| Chevy Chase Trust Holdings, LLC |
13F
|
Company |
0.48%
|
591,965
|
$74,002,000 | — | 30 Sep 2021 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.46%
|
568,409
|
$71,057,000 | — | 30 Sep 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.43%
|
530,983
|
$66,379,000 | — | 30 Sep 2021 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.4%
|
492,776
|
$61,602,000 | — | 30 Sep 2021 | |
| Senator Investment Group LP |
13F
|
Company |
0.36%
|
450,000
|
$56,254,000 | — | 30 Sep 2021 | |
| Ardevora Asset Management LLP |
13F
|
Company |
0.36%
|
441,220
|
$55,157,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.34%
|
423,057
|
$52,886,000 | — | 30 Sep 2021 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.34%
|
420,204
|
$52,529,000 | — | 30 Sep 2021 | |
| MOORE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.34%
|
418,340
|
$52,297,000 | — | 30 Sep 2021 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
0.31%
|
389,600
|
$48,704,000 | — | 30 Sep 2021 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.31%
|
387,984
|
$48,502,000 | — | 30 Sep 2021 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.28%
|
350,030
|
$43,757,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.28%
|
342,760
|
$42,847,000 | — | 30 Sep 2021 | |
| Bellevue Group AG |
13F
|
Company |
0.27%
|
339,894
|
$42,490,000 | — | 30 Sep 2021 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.26%
|
325,171
|
$40,650,000 | — | 30 Sep 2021 | |
| Hitchwood Capital Management LP |
13F
|
Company |
0.26%
|
320,000
|
$40,003,000 | — | 30 Sep 2021 | |
| Railway Pension Investments Ltd |
13F
|
Company |
0.25%
|
307,978
|
$38,500,000 | — | 30 Sep 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.25%
|
307,407
|
$38,428,000 | — | 30 Sep 2021 |
Institutional Holders of Guardant Health, Inc. - Common Stock (GH) as of Q4 2021
As of 31 Dec 2021,
Guardant Health, Inc. - Common Stock (GH) was held by
379 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
92,085,897 shares.
The largest 10 holders included
VANGUARD GROUP INC, Capital Research Global Investors, FMR LLC, MORGAN STANLEY, BlackRock Inc., VIKING GLOBAL INVESTORS LP, Clearbridge Investments, LLC, Capital International Investors, Nuveen Asset Management, LLC, and CREDIT SUISSE AG/.
This page lists
380
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
365
Q4 2021 holders
379
Holder diff
14
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.